In the current pandemic, finding an effective drug to prevent or treat the infection is the
highest priority. A rapid and safe approach to counteract COVID‐19 is in silico drug …

The emergent outbreak caused by severe acute respiratory syndrome coronavirus 2
continues spreading and causing huge social and economic disruption. Papain-like …

The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a
high transmission rate with currently no drugs or vaccines approved. An alternative powerful …

Finding an effective drug to prevent or treat COVID-19 is of utmost importance in tcurrent
pandemic. Since developing a new treatment takes a significant amount of time, drug …

A new coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2), is a highly contagious virus and has caused a massive worldwide health crisis …

The outbreak of SARS‐CoV‐2 has become a threat to global health and has led to a global
economic crisis. Although the researchers worldwide are putting tremendous effort toward …

The world has witnessed of many pandemic waves of SARS-CoV-2. However, the incidence
of SARS-CoV-2 infection has now declined but the novel variant and responsible cases has …

As an extension of our research against COVID-19, a multiphase in silico approach was
applied in the selection of the three most common inhibitors (Glycyrrhizoflavone (76) …

The development of inhibitors that target the papain‐like protease (PLpro) has the potential
to counteract the spread of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV …

The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
companion disease, COVID-19, has reminded us of the importance of basic coronaviral …